3 Small Biotech Stocks Being Run by Proven Winners
Great leaders are important in any industry, but perhaps they're even more valuable in biotech, where any number of clinical-stage and regulatory obstacles can derail drug research and send share prices reeling. For that reason, investing in biotech stocks such as Aurinia Pharmaceuticals (NASDAQ: AUPH), Axovant Sciences (NYSE: AXON), and Esperion Therapeutics (NASDAQ: ESPR) -- all of which are run by proven leaders -- could be savvy.
Aurinia Pharmaceuticals' C-suite is packed with ex-Aspreva Pharmaceuticals executives who know a thing or two about lupus nephritis (LN).
IMAGE SOURCE: GETTY IMAGES.
Source: Fool.com
Pfizer Inc. Aktie
Die Pfizer Inc. Aktie steht gut da: Deutlich mehr Buy- als Sell-Einschätzungen in der Community.
Das Kursziel von 41 € für Pfizer Inc. impliziert eine deutliche Steigerung um über 50% gegenüber 25.77 €.